Key result
Young adults with prior asymptomatic or mild COVID-19 had significantly lower 1-MSTST repetitions and 6MWT distance compared to healthy controls at both 3-6 and 6-12 months post-infection.
Why the study?
Long COVID-19 syndrome may cause functional difficulties in young people, prompting an investigation of respiratory and functional sequelae in young adults after asymptomatic or mild COVID-19 compared to healthy peers.
Does asymptomatic or mild COVID-19 infection reduce respiratory and physical function in young adults compared to healthy controls?
Cross-Sectional (n=75)
Does asymptomatic or mild COVID-19 infection reduce respiratory and physical function in young adults compared to healthy controls?
Young adults with a history of asymptomatic or mild COVID-19 exhibit significant declines in physical function and lower extremity muscle performance up to 6-12 months post-infection.
Persistent symptoms may linger in young adults after mild COVID; leaves open need for prospective studies before clinical action.
Background and Objectives: Long COVID-19 syndrome may cause difficulties in functionality during daily life in young people. Our objective was to investigate the respiratory and functional sequelae in young adults with asymptomatic or mild COVID-19 compared with healthy peers 3–6 months and 6–12 months after COVID-19 infection. Materials and Methods: Participants aged 18–25 who had COVID-19 within the last 3–6 months (Post-COVID Group 1, n = 25) and 6–12 months (Post-COVID Group 2, n = 25) and age–gender-matched healthy controls (n = 25) were included in this study. Respiratory functions and muscle strength were measured. Physical function was assessed with 6 min walking test (6MWT) and an Incremental Shuttle Walk Test (ISWT). The 1 min sit-to-stand test (1-MSTST) and hand grip strength (HGS) were used to assess muscle performance. Fatigue and dyspnea severity were questioned. Results: The FVC%pred (p = 0.023) and MEP (p = 0.034) were higher, and 1-MSTST repetitions were lower in Post-COVID Group-1 compared to Post-COVID Group-2 (p = 0.029). The PEF%pred (p = 0.025), MEP (p = 0.001), and ISWT distance were lower in Post-COVID Group-2 compared to healthy controls. The number of 1-MSTST repetitions and 6MWT distance were lower in Post-COVID Group-1 (p = 0.003, p = 0.001) and Post-COVID Group-2 (p = 0.003, p = 0.017) than in healthy controls. Exercise-induced blood lactate change during the ISWT, HGS, fatigue, and dyspnea were not significantly different between post-COVID groups and healthy controls. Conclusions: Young adults who pass asymptomatic or mild SARS-CoV-2 infection exhibit a decline in FVC%pred, PEF%pred, lower extremity muscle performance, and physical function within 3–6 months. In addition, the deterioration in respiratory and physical functions becomes apparent within 6–12 months.
No takes yet. Share an insight, caveat, or question.
Ekşi et al. (2025) conducted a cross-sectional in Post-COVID-19 (n=75). Asymptomatic or mild COVID-19 infection vs. Healthy controls was evaluated on Respiratory functions, muscle strength, and physical function. Young adults with prior asymptomatic or mild COVID-19 had significantly lower 1-MSTST repetitions and 6MWT distance compared to healthy controls at both 3-6 and 6-12 months post-infection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: